DOCSLIB.ORG

ESMO 2014 Advanced Programme

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

esmocongress.org ADVANCED PROGRAMME ESMO 2014 Madrid, Spain 26-30 SEPTEMBER 2014 IMPORTANT DEADLINES 07 May 2014 Abstract submission and travel grant applications 18 June 2014 Early registration Organiser 23 July 2014 Group registration, participant names to be given 20 August 2014 Late-breaking abstract submission 20 August 2014 Late registration BASIC SCIENCE AND TRANSLATIONAL RESEARCH Saturday, 27 September 2014 Monday, 29 September 2014 10:30/ PATIENT CASES 11:00/ SPECIAL SYMPOSIUM 11:30 Cancer evolution: What can we learn from N=1 12:30 Genomic instability from bench to bedside molecular studies? Chair: Sheila Singh, Hamilton, ON, Canada Co-Chairs: Michael Taylor, Toronto, ON, Canada and Tariq Enver, Co-Chair: Charles Swanton, London, UK London, UK Introduction Evolution of acute lymphoblastic leukemia (ALL) in identical twins Charles Swanton, London, UK Tariq Enver, London, UK The emerging role of HELQ in homologous recombination repair Clonal evolution of childhood cancers in ovarian cancer Michael Taylor, Toronto, ON, Canada Rebecca Burrell, London, UK Discussion Replication stress and DNA damage response in solid tumours Jiri Bartek, Copenhagen, Denmark The interface between cancer numerical and structural Sunday, 28 September 2014 chromosomal instability: Mechanisms accelerating cancer diversity 09:15/ JOINT SYMPOSIUM: ESMO - JSMO 10:45 How to implicate genome sequencing data in oncology René Medema, Amsterdam, Netherlands Co-Chairs: Jean-Yves Douillard, St. Herblain, France and Targeting cancer aneuploidy: Light at the end of the tunnel? Atsushi Ohtsu, Kashiwa, Japan Tak Mak, Toronto, ON, Canada Introduction Conclusions and clinical perspectives Jean-Yves Douillard, St. Herblain, France Sheila Singh, Hamilton, ON, Canada Potentially druggable gene alterations in gastrointestinal cancer Tatsuhiro Shibata, Tokyo, Japan A new molecular taxonomy for colorectal cancer – What are the therapeutic implications? To be announced New insight of sequencing data in lung cancer Kazuto Nishio, Osaka, Japan Overcoming implementation challenges of personalised cancer therapy in patients with breast cancer Fabrice André, Villejuif, France Conclusions Atsushi Ohtsu, Kashiwa, Japan 13:00/ KEYNOTE LECTURE 13:45 Reclassifying cancer through genomics Chair: Jos Jonkers, Amsterdam, Netherlands Speaker: Michael Stratton, London, UK SCIENTIFIC COMMITTEE Charles Swanton, London, UK, Chair Jiri Bartek, Copenhagen, Denmark Jos Jonkers, Amsterdam, Netherlands René Bernards, Amsterdam, Netherlands Tak Mak, Toronto, ON, Canada Rebecca Burrell, London, UK Carlo Maley, San Franscisco, CA, USA Carlos Caldas, Cambridge, UK Sheila Singh, Hamilton, ON, Canada Robert Gatenby, Tampa, FL, US Yosef Yarden, Rehovot, Israel Ramaswamy Govindan, St. Louis, MO, US Session timings may be subject to change within the same day 9 BREAST CANCER Saturday, 27 September 2014 Sunday, 28 September 2014 09:00/ EDUCATIONAL SESSION 08:00/ PATIENT CASES 10:30 Update in the management of metastatic breast 09:00 Targeting intrinsic subtypes of metastatic breast cancers cancer: The spectrum of sensitivity to endocrine Chair: Angelo Di Leo, Prato, Italy therapy Co-Chair: Hernan Cortes-Funes, Madrid, Spain Co-Chairs: Philippe Bedard, Toronto, ON, Canada and Integration of molecular analyses in the management of Javier Cortes, Barcelona, Spain metastatic breast cancer Overcoming resistance in ER positive disease Nicholas Turner, London UK Philippe Bedard, Toronto, ON, Canada Hormonal therapy Dealing with heterogeneity of triple negative breast cancer: From Ian Smith, London, UK luminal androgen receptor to mesenchimal stem like subtype Optimal therapy for R2 positive Javier Cortes, Barcelona, Spain Angelo Di Leo, Prato, Italy Discussion 11:00/ EDUCATIONAL SESSION 09:15/ SPECIAL SYMPOSIUM 12:30 Management of breast cancer in specific populations 10:45 Residual disease after neoadjuvant therapies Chair: Fatima Cardoso, Lisbon, Portugal Chair: Evandro de Azambuja, Brussels, Belgium Co-Chair: to be announced Co-Chair: Suzette Delaloge, Villejuif, France Management of breast cancer in elderly patients Introduction Etienne Brain, Saint Cloud, France Suzette Delaloge, Villejuif, France Management of breast cancer in very young and pregnant Quantifying post-neo adjuvant therapy residual disease and its women impact on relapse risk Sybille Loibl, Neu-Isenburg, Germany Fraser Symmans, Houston, TX, US Management of breast cancer in males Biological profiling of residual disease Fatima Cardoso, Lisbon, Portugal Frederique Penault-Llorca, Clermont-Ferrand, France 16:00/ EDUCATIONAL SESSION (REPETITION) Molecular imaging: Are we able to predict for residual disease? 17:30 Management of breast cancer in specific populations Andreas Makris, Northwood, UK Chair: Fatima Cardoso, Lisbon, Portugal How to design clinical trials in a post neo-adjuvant setting? Co-Chair: to be announced Andrew Tutt, London, UK Management of breast cancer in elderly patients Conclusions and clinical perspectives Etienne Brain, Saint Cloud, France Evandro de Azambuja, Brussels, Belgium Management of breast cancer in very young and pregnant 14:15/ EDUCATIONAL SESSION (REPETITION) women 15:45 Update in the management of metastatic breast Sybille Loibl, Neu-Isenburg, Germany cancers Management of breast cancer in males Chair: Angelo Di Leo, Prato, Italy Fatima Cardoso, Lisbon, Portugal Co-Chair: Hernan Cortes-Funes, Madrid, Spain Integration of molecular analyses in the management of metastatic breast cancer Nicholas Turner, London UK Hormonal therapy Ian Smith, London, UK Optimal therapy for R2 positive Angelo Di Leo, Prato, Italy SCIENTIFIC COMMITTEE (EARLY STAGE) Evandro De Azambuja, Brussels, Belgium, Chair Hatem Azim, Brussels, Belgium Sabine C. Linn, Amsterdam, Netherlands Agusti Barnadas, Barcelona, Spain Carlo Palmieri, Liverpool, UK Fatima Cardoso, Lisbon, Portugal Alastair Thompson, Dundee, UK Boon Chua, Melbourne, Australia Andrew Tutt, London, UK Angelo Di Leo, Prato, Italy Giuseppe Viale, Milan, Italy Peter Dubsky, Vienna, Austria 10 Session timings may be subject to change within the same day Monday, 29 September 2014 08:00/ CHALLENGE YOUR EXPERT (CYE) 14:15/ JOINT SYMPOSIUM: ESMO - ESTRO - ESSO 09:00 Adjuvant treatment of breast cancer 15:45 Integration of local therapy with systemic treatment in Speaker: Martine Piccart, Brussels, Belgium oligometastatic breast cancer Co-Chairs: Christoph Zielinski, Vienna, Austria; Philip Poortmans, 09:15/ SPECIAL SYMPOSIUM Tilburg, Netherlands and Riccardo A. Audisio, St. Helens, UK 10:45 Cancer immunotherapy in breast cancer: Dream or Introduction reality? Christoph Zielinski, Vienna, Austria Chair: Giuseppe Curigliano Milan, Italy Co-Chair: Sherene Loi, Melbourne, Australia Combining systemic treatment with radiation therapy: Quantifying the therapeutic gain Introduction Per Karlsson, Gothenburg, Sweden Giuseppe Curigliano Milan, Italy Design of clinical trials integrating local treatments with systemic Modulation of immune response in breast cancer and clinical therapy for M1 disease implications of tumour dormancy To be announced Sherene Loi, Melbourne, Australia The role of surgery for M1 breast cancer Diagnostic and therapeutic implications of tumour-infiltrating lymphocytes in breast cancer Marjut Leidenius, Helsinki, Finland Carsten Denkert, Berlin, Germany The role of radiation therapy for M1 breast cancer Philip Poortmans, Tilburg, Netherlands Contribution of immune response to anti-tumour effect of chemotherapy Conclusions Carmen Criscitiello, Naples, Italy Riccardo A. Audisio, St. Helens, UK Design of the ideal trial with immunotherapeutics 16:00/ PATIENT CASES Giuseppe Curigliano Milan, Italy 17:00 Challenges in managing breast cancer in young Conclusions and clinical perspectives patients Sherene Loi, Melbourne, Australia Co-Chairs: Hatem A. Azim, Brussels, Belgium; Marco Colleoni, Milan, Italy and Sabine Linn, Amsterdam, Netherlands Genetic testing: When and for whom? Sabine Linn, Amsterdam, Netherlands Fertility counselling: What are the options? Hatem A. Azim, Brussels, Belgium, Optimal adjuvant hormonal therapy in premenopausal women Marco Colleoni, Milan, Italy Discussion Tuesday, 30 September 2014 08:00/ CYE (REPETITION) 09:00 Adjuvant treatment of breast cancer Speaker: Martine Piccart, Brussels, Belgium SCIENTIFC COMMMITEE (METASTATIC) Giuseppe Curigliano, Milan, Italy, Chair Philippe Bedard, Toronto, ON, Canada Per Karlsson, Gothenburg, Sweden Javier Cortes, Barcelona, Spain Antonio Llombart, Valencia, Spain Carmen Criscitiello, Milan, Italy Sherene Loi, Melbourne, Australia Carsten Denkert, Berlin, Germany Sibylle Loibl, Neu-Isenburg, Germany Luca Gianni, Milan, Italy Nicholas Turner, London, UK Roger Gomis, Barcelona, Spain Session timings may be subject to change within the same day 11 CNS TUMOURS Sunday, 28 September 2014 09:15/ EDUCATIONAL SESSION 14:15/ SPECIAL SYMPOSIUM 10:45 Actual issues in neurooncology 15:45 Current concepts and future avenues in meningioma Chair: Roger Stupp, Zurich, Switzerland Chair: Jörg-Christian Tonn, Munich, Germany Co-Chair: Mario Campone, St. Herblain, France Co-Chair: Matthias Preusser, Vienna, Austria Brain metastases: To treat or not to treat? Introduction Roger Stupp, Zurich, Switzerland Jörg-Christian Tonn, Munich, Germany Molecular marker-based clinical decision-making today Meningioma: What can we learn from the biology for precision Michael Weller, Zurich, Switzerland medicine? Approaches to recurrent glioblastoma Michel Kalamarides, Paris, France Alba Brandes, Bologna, Italy Classification and molecular
Recommended publications
  • Across the Universe? a Comparative Analysis of Violent Behavior And

    Across the Universe? a Comparative Analysis of Violent Behavior And

    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Across the Universe? A Comparative Analysis of Violent Behavior and Radicalization Across Three Offender Types with Implications for Criminal Justice Training and Education Author(s): John G. Horgan, Ph.D., Paul Gill, Ph.D., Noemie Bouhana, Ph.D., James Silver, J.D., Ph.D., Emily Corner, MSc. Document No.: 249937 Date Received: June 2016 Award Number: 2013-ZA-BX-0002 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this federally funded grant report available electronically. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Across the Universe? A Comparative Analysis of Violent Behavior and Radicalization Across Three Offender Types with Implications for Criminal Justice Training and Education Final Report John G. Horgan, PhD Georgia State University Paul Gill, PhD University College, London Noemie Bouhana, PhD University College, London James Silver, JD, PhD Worcester State University Emily Corner, MSc University College, London This project was supported by Award No. 2013-ZA-BX-0002, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the Department of Justice 1 ABOUT THE REPORT ABOUT THE PROJECT The content of this report was produced by John Horgan (Principal Investigator (PI)), Paul Gill (Co-PI), James Silver (Project Manager), Noemie Bouhana (Co- Investigator), and Emily Corner (Research Assistant).
  • Andreu Dameson

    Andreu Dameson

    Andreu Dameson i Aspa (La Garriga, 1897 - Buenos Aires, 1968) personatge inquiet ANDREU i seductor, va viure a cavall de la Catalunya natal i l’Argentina d’adopció, deixant en DAMESON ambdós països una memorable petjada tant professional com vital. El seu compromís d’esquerres, republicà i catalanista el portaren a un exili del que GENI DE LA no pogué tornar ja mai més i ha estat la causa de l’injustifi cat oblit de la seva impor- CARICATURA tant obra, al qual aquest llibre vol posar-hi fi . Dameson, dibuixant, pintor, il·lustrador, periodista, escriptor... es defi nia, per da- munt de tot, com a caricaturista. Sens dubte, en fou un dels millors del segle XX. LLUÍS SOLÀ I DACHS JAUME CAPDEVILA Lluís Solà i Dachs (Barcelona, 1932) Jaume Capdevila i Herrero «Kap» GENI DE LA CARICATURA Enginyer tèxtil. Ha estudiat la premsa humorística il·lustrada (Berga, 1974) catalana i ha publicat antologies dels setmanaris més Llicenciat en Belles Arts per la UB. populars. Les seves obres principals són Dibuixant d’humor, il·lustrador L’humor català (3 vols.), El Be Negre (2 vols.), i caricaturista. Ha publicat, Història dels diaris en català, L’humor culer entre d’altres, a La Vanguardia, (amb el dibuixant Cesc), La caricatura política i social a Mundo Deportivo i El Triangle. Catalunya i Papitu i les publicacions erótico-sicalíptiques Ha estudiat destacats ninotaires del seu temps, entre altres. catalans com Lluís Bagaria Ha dirigit i col·laborat en diverses exposicions o Tísner. El 2009 va rebre i ha publicat nombrosos articles en diaris, el Premi Internacional ANDREU DAMESON ANDREU DAMESON revistes i catàlegs.
  • Kountze Genealogy

    Kountze Genealogy

    Descendants of Christian Gotlieb Kountze Generation No. 1 1. CHRISTIAN GOTLIEB1 KOUNTZE (JOHANN MICHELA KUNZE, JOHANN MICHAELB KUNZ) was born 04 Apr 1795 in Burkersdorf, Saxony, Germany, and died 24 Jan 1866 in Osnaburg, Stark County, OH. He married MARGARET ZERBE 24 Jan 1826 in Osnaburg, Stark County, OH, daughter of JOHN (ZERBE) and BARBARA SCHAEFFER. She was born 23 Feb 1807 in Near Greensburg, Western Orchard County, PA, and died 23 Feb 1887 in Hazelwood, near Pittsburgh, Allegheny Co., PA. More About CHRISTIAN KOUNTZE and MARGARET ZERBE: Marriage: 24 Jan 1826, Osnaburg, Stark County, OH Children of CHRISTIAN KOUNTZE and MARGARET ZERBE are: i. AUGUSTUS2 KOUNTZE, b. 19 Nov 1826, Osnaburg, Stark County, OH; d. 30 Apr 1892, New York, NY; m. CATHERINE RUTH, 14 Jun 1849; b. 1826, Hanoverton, Ohio. More About AUGUSTUS KOUNTZE and CATHERINE RUTH: Marriage: 14 Jun 1849 ii. MATILDA KOUNTZE, b. 22 Apr 1828, Osnaburg, Stark County, OH; m. (1) SAMUEL PHILLIP, 11 Sep 1845; m. (2) JAMES GARDINER, 10 Mar 1859. More About SAMUEL PHILLIP and MATILDA KOUNTZE: Marriage: 11 Sep 1845 More About JAMES GARDINER and MATILDA KOUNTZE: Marriage: 10 Mar 1859 2. iii. ADALINE KOUNTZE, b. 23 Jul 1830, Osnaburg, Stark County, OH. iv. ADOLPHUS CHRISTIAN KOUNTZE, b. 04 Aug 1832, Osnaburg, Stark County, OH; d. 23 Aug 1832, Osnaburg, Stark County, OH. 3. v. HERMAN KOUNTZE, b. 21 Aug 1833, Osnaburg, Stark County, OH; d. 20 Nov 1906, Omaha, NE. vi. WILLIAM KOUNTZE, b. 11 Apr 1836, Osnaburg, Stark County, OH; d. 06 Sep 1858, Dakota City, SD. 4. vii.
  • Heavyweight Cruiserweight Light Heavyweight

    Heavyweight Cruiserweight Light Heavyweight

    WBA RATINGS COMMITTEE MARCH 2013 MOVEMENTS REPORT Based on results held from 03st March to 31th, 2013 Miguel Prado Sanchez Chairman Gustavo Padilla Vice Chairman HEAVYWEIGHT DATE PLACE BOXER A RESULT BOXER B TITLE REMARKS 03-08-2013 Atlantic city, New Jersey Magomed Abdusalamov KOT5 Victor Bisbal USNBC-WBC 03-23-2013 Berlin, Germany Ruslan Chagaev KO1 Mike Sheppard M. Brozio 60-54 P. Koslowski 59-56 03-23-2013 Czestochowa ,Poland Andrzej Wawrzyk UD 6 Robert Hawkins P. Moszumanski 60-54 MOVEMENT OUT Richard Towers out off to position # 13 by inactivity. (283 days) IN Malik Scott enters at position # 15 by caliber and activity # 14 Travis Kaufman goes up to position # 13 by automatic movement PROMOTIONS # 15 Mark De Mori goes up to position # 14 by automatic movement DEMOTIONS CRUISERWEIGHT DATE PLACE BOXER A RESULT BOXER B TITLE REMARKS MOVEMENT OUT NOT CHANGES IN NOT CHANGES PROMOTIONS NOT CHANGES DEMOTIONS NOT CHANGES LIGHT HEAVYWEIGHT 1 DATE PLACE BOXER A RESULT BOXER B TITLE REMARKS A. Van vangrootenbruel 115-113 Y.Koptev 115-113 03-16-2013 Kiev,Ukranie Doudov Ngumbu UD 12 Vyacheslav Uzelkov N.Monnet 116-113 03-22-2013 Quebec,Canada Eleider Alvarez KOT 3 Nocholson Poulard NABA,NABO M0VEMENT Vyacheslav Uzelkov out off to position # 4 by losing to a boxer unclassified as established by regulation OUT Nicholson Poulard out off to position # 6 by losing to a boxer unclassified as established by regulation Eleider Alvarez enters at position # 5 for winning a boxer classified and is a new champion NABA IN Doudou Ngumbu enters at position
  • Boston Medical Center VSGNE 2003 9 Member Hospitals

    Boston Medical Center VSGNE 2003 9 Member Hospitals

    Vascular Study Group of New England 16th Semi-Annual Meeting May 11, 2010 Boston Medical Center VSGNE 2003 9 Member Hospitals Fletcher Allen Health Eastern Maine Medical Center Care Cottage Hospital Central Maine Medical Center Dartmouth-Hitchcock Lakes Region Medical Center Hospital Maine Medical Center Concord Hospital Catholic Medical Center VSGNE 2011 27 Participating Hospitals 25 - 950 Hospital Beds Fletcher Allen Eastern Maine Medical Center Health Care Cottage Maine General Medical Center Hospital Central Maine Medical Center Dartmouth-Hitchcock Lakes Region Medical Center Hospital Maine Medical Center Rutland Regional Mercy Hospital Medical Center Concord Hospital Catholic Medical Center Elliot Hospital Berkshire Medical Center Tufts Medical Center Boston Medical Center U. Mass. Medical Center Beth Israel Deaconess Medical Center Baystate Medical Center Massachusetts General Hospital Brigham & Women’s Hospital Charlton Memorial Hospital St. Francis Hospital Caritas St. Anne’s Hospital Hartford Hospital St. Luke’s Hospital Yale-New Haven Hospital VSGNE 2011 27 Participating Hospitals 14 Community - 13 Academic Fletcher Allen Eastern Maine Medical Center Health Care Cottage Maine General Medical Center Hospital Central Maine Medical Center Dartmouth-Hitchcock Lakes Region Medical Center Hospital Maine Medical Center Rutland Regional Mercy Hospital Medical Center Concord Hospital Catholic Medical Center Elliot Hospital Berkshire Medical Center Tufts Medical Center Boston Medical Center U. Mass. Medical Center Beth Israel Deaconess Medical Center Baystate Medical Center Massachusetts General Hospital Brigham & Women’s Hospital Charlton Memorial Hospital St. Francis Hospital Caritas St. Anne’s Hospital Hartford Hospital St. Luke’s Hospital Yale-New Haven Hospital “Real World Practice” Maine New Hampshire Massachusetts Massachusetts Continued Connecticut Central Maine Medical Center, Lewiston Catholic Medical Center, Manchester Baystate Medical Center, Springfield Tufts Medical Center, Boston St.
  • Hardwick Will Iol Velvet Rugs

    Hardwick Will Iol Velvet Rugs

    SERMON BY BISHOP BRENT. ^ TTTTTTTTTTTTYi 4> MARRIEiD THIS AFTERr^JOON. SHIRTS BLANKETS comer Stone of Episcopal Chapel to ' * Be Placed Tuesday Next. CURTAINS COLLARS 4 -[ The Rt. Rev. Charles "]Favors" and Henry Brent, Original % < | to CUFFS . r LINGERIE piscopal missionary bishop the PhU- } ' V I pi nee. who »as twice electe<l aucceaaor the the late Bishop Sattcrlee as Bishop of 2 "Stouts" to Intensify $ I 'ashlngton. ami declined, will preach *» ie sermon at the laying of the corner one of the Bethlehem Chapel of the * olv Nativity next Tuesday afternoon i Fumi am Interest 11 The services will begin at .1 o'clock, TJ i VnBpiB^j^^l^^^^aE Ksi^B.1 11 yii itli Bishop Harding presiding and f « in the stone. Canons De Vrles and Bra-larg ^ o nahl are in charge of the arrangements. I.itt'.c Henry Y. tsatterlee, grandson of in the isliop batterlee, » 11) be present and as- j ± Bnnoimcement. st in the ceremonies of tin- A II U day. | rgo vested choir ami a se ti<>n of the \ arine Band will al>o participate The stone will be laid in the crypt of * f W.CTIf!fIM ! ie cathedral, and directly beneath tha Mj&Jjjuly) iffl JyM] ii iyyiiiiiiiiiiiiiyu/D ^ de HA>iD laneel. -. SALES N LAUNDRY. ^ ^ 110-1\ Conn. r You will find it eas^ to your for an Formerly Ave.) w perfect plans I. C. A. Alumnae. ma ^ \i .%*4?:: -' l.ast the a.umnae of Jl interesting and original Halloween Fete after you've iikhkm../ ^h^^e^kxkb^mhhqb Moml*;.
  • Scientific Report 2019

    Scientific Report 2019

    2006 2007 2008 2009 2010 2011 2012 2013 2014 Tick tock toward 2025 toward tock Tick 2019 REPORT SCIENTIFIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Vall d'Hebron Institute of Oncology (VHIO) CELLEX CENTER C/Natzaret, 115 – 117 08035 Barcelona, Spain Tel. +34 93 254 34 50 www.vhio.net Direction: Amanda Wren Photography: Katherin Wermke Design: Parra estudio Vall d'Hebron Institute of Oncology (VHIO) | 2020 VHIO’s Scientific Report 2019: tick tock toward 2025 1 VHIO’s CELLEX CENTER: translation toward precision oncology 2 VHIO Scientific Report 2019 VHIO’s Scientific Report 2019: tick tock toward 2025 Index VHIO Scientific Report 2019 INTRODUCING VHIO 6 Foreword by VHIO’s Director 16 VHIO in 2019: Tick tock toward 2025 42 Scientific Productivity: research articles 43 Selection of some of the most relevant articles by VHIO researchers published in 2019 FROM THE PROGRAM DIRECTORS 52 Joaquín Arribas 54 Joan Seoane 56 Josep Tabernero PRECLINICAL & TRANSLATIONAL RESEARCH 64 Cellular Plasticity & Cancer Group 66 Chromatin Dynamics in Cancer Group 68 Experimental Therapeutics Group 70 Gene Expression & Cancer Group 72 Growth Factors Group 74 Mouse Models of Cancer Therapies Group 76 Stem Cells & Cancer Group 78 Tumor Biomarkers Group CLINICAL RESEARCH 82 Breast Cancer & Melanoma Group 84 Early Clinical Drug Development Group 86 Experimental Hematology Group 88 Gastrointestinal & Endocrine Tumors Group 90 Genitourinary, CNS Tumors, Sarcoma & Cancer of Unknown Primary Site Group 92 Gynecological Malignancies Group 94 Hereditary Cancer
  • 2018 Detailed Annual Report

    2018 Detailed Annual Report

    2018 Detailed Annual Report © Society for Vascular Surgery Patient Safety Organization, 2018. All rights reserved. TABLE OF CONTENTS 1. Executive Summary: The Value of Participation in the VQI 3 2. VQI Members Profile 5 3. Outcomes and Data Quality Dashboards 6 4. Regional Quality Groups 7 5. Quality Improvement Projects: Learning from the Data 8 6. VQI National QI Projects 9 7. VQI Data Analysis 12 8. Using VQI Data for Collaborative Projects 12 9. Future Developments 15 APPENDICES A. Participating Sites 17 B. SVS Patient Safety Organization 19 C. Medstreaming/M2S Technology Partner 19 D. VQI Registry Dashboards 20 E. Sample COPI Report (Endovascular AAA Length of Stay) and Best Practice Dashboard (Center-level) 32 F. VQI Regional Quality Groups and Leadership 37 G. VQI Quality Improvement Projects 2017/18 38 H. National Approved Project List, October 2017 – September 2018 39 I. National Publications, October 2017 – September 2018 44 J. SVS PSO Councils and Registry Committees 49 2 SVS VQI 2018 Annual Report 1. EXECUTIVE SUMMARY—THE VALUE OF PARTICIPATION IN THE VASCULAR QUALITY INITIATIVE (VQI) “If you can’t measure it, you can’t improve it.” This management catchphrase has been attributed to Edwards Deming, Peter Drucker, Lord Kelvin and others, but it could serve as the founding principle of the Vascular Quality Initiative. Our mission is to gath- er data to help hospitals and providers assess their performance and provide better vascular care. VQI’s 12 registries contain demographic, clinical, use the strength of different societies (VQI, NCDR, procedural and outcomes data from more and SIR) to enhance device evaluation and than 500,000 vascular procedures performed to develop objective performance criteria for nationwide and in Canada.

  • American Society of Clinical Oncology (ASCO) Annual Meeting 2019 Friday, May 31 – Tuesday, June 4

    American Society of Clinical Oncology (ASCO) Annual Meeting 2019 Friday, May 31 – Tuesday, June 4 https://am.asco.org/ Cancer Center Members indicated in BOLD Presentations and Session Chairs Mikkael A. Sekeres, MD, MS, Cleveland Clinic Taussig Cancer Institute Interactive Case-Based Session: Do We Know How to Use Hypomethylating Agents in Myeloid Disorders? Speaker, “What Is the Right Decitabine Treatment Duration?” Friday, May 31, 2019, 1:00 PM - 2:00 PM, E451 Nathan A. Pennell, MD, PhD, Cleveland Clinic Chair, Education Session: Real-World Tumor/Plasma Genetic Testing: Tough Choices, How Do You Pick? Speaker, “Guidelines, Barriers, Access to Molecular Testing in NSCLC” Friday, May 31, 2019, 2:45 PM - 3:00 PM, Hall D1 Pradnya Dinkar Patil, MD, FACP, Cleveland Clinic Education Session: On the Shoulders of Giants: Past, Present, and Future of Systemic Therapy for Lung Cancer Speaker, “The Next Frontier: Understanding and Overcoming Resistance to Targeted Therapy and Immunotherapy” Friday, May 31, 2:45 PM – 4:00 PM, S100bc Eric Kodish, MD, Cleveland Clinic Chair, Education Session: Obtaining Consent in Pediatric Oncology: New and Ongoing Challenges Speaker, “Ethical Care Practices: Respecting Cultural and Societal Differences to Safeguard the Therapeutic Relationship” Monday, June 3, 2019, 8:00 AM – 8:20 AM, S504 Jennifer S. Yu, MD, PhD, Cleveland Clinic Chair, Education Session: Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal? Speaker, “To Radiate or Not to Radiate: Nuances of Radiation Therapy for Low-Grade Gliomas” Monday, June 3, 2019, 10:00 AM – 10:15 AM, E451 Brian I. Rini, MD, FACP, Cleveland Clinic Taussig Cancer Institute Panelist, Interactive Case-Based Session: Emerging New Standards of Care for Advanced Kidney Cancer Monday, June 3, 2019, 11:30 AM – 12:30 PM, E451 Cancer Center members indicated in BOLD Alberto J.
  • ITOC4 Programme

    ITOC4 Programme

    Presented by CDDF in collaboration with SITC: THE LEADING INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE IN EUROPE 20 MARCH 22 2017 FINAL PROGRAMME PRAGUE CZECH REPUBLIC 5TH Immunotherapy Of Cancer Conference THE LEADING INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE IN EUROPE cancer cell © vitanovski MARCH 19-21, 2018 BERLIN, GERMANY 5TH EDITION MARCH 19-21, 2018 BERLIN, GERMANY www.itoc-conference.eu SAVE THE DATE 4TH IMMUNOTHERAPY OF CANCER CONFERENCE TABLE OF CONTENTS WELCOME LETTER PAGE 4 CANCER DRUG DEVELOPMENT FORUM & PARTNERS PAGE 5 ORGANISING PARTNERS PAGE 5 CONFERENCE COMMITTEE PAGE 6 ACCREDITATION FOR CONTINUOUS MEDICAL EDUCATION (CME) PAGE 6 PROGRAMME AT A GLANCE PAGE 7 SCIENTIFIC PROGRAMME PAGE 8 POSTERS PAGE 10 FLOORPLAN PAGE 13 ACKNOWLEDGMENTS PAGE 14 EXHIBITORS PAGE 15 PARTNERS PAGE 16 GENERAL INFORMATION PAGE 17 CORPORATE SATELLITE SYMPOSIUM PAGE 21 FINAL PROGRAMME FINAL 3 4TH IMMUNOTHERAPY OF CANCER CONFERENCE WELCOME LETTER Welcome to the fourth edition of the Immunotherapy of Cancer conference (ITOC4), the premier meeting for education, scientific exchange and networking within cancer immunotherapy. This meeting has been growing rapidly into a global platform for translational research in the field of immuno-oncology. The scientific programme with an international faculty will focus on many topics such as Preclinical models, Micro-environment and Immune Regulation, Emerging concepts and novel targets, Combination therapy, Monitoring of immune response in the clinic, Therapeutic antibodies and Cell therapy. Organised by the Cancer Drug Development Forum (CDDF), whose mission is to provide a unique platform to facilitate interactions between all stakeholders (academia, regulatory authorities, policymakers, industry, patient advocacy groups and health technology assessors) to improve the efficiency of cancer drug development and in cooperation with Society for Immunotherapy of Cancer (SITC), the ITOC conference series aim to provide a forum for discussion of early clinical drug development and address its unique challenges.
  • Sin Título-1

    Sin Título-1

    International Awards Premis Internacionals XVII EDICIÓ 8 D’OCTUBRE DE 2015 AUDITORI DE GIRONA ELS PREMIS INTERNACIONALS LIBERPRESS LiberPress va néixer a Girona l’any 1999. Es va crear LiberPress és una associació de caràcter no amb la idea de donar a conèixer i promocionar el governamental, humanitària i sense ànim de lucre que podriem anomenar “cultura de la solidaritat”. que té entre els seus objectius organitzar Amb la seva creació es pretenia formar un conferències, congressos, debats, fòrums, moviment solidari i humanitari, amb el qual exposicions, jornades, actuacions i qualsevol acte s’impliquessin els mitjans de comunicació, que es de caràcter cultural i reivindicatiu per promoure una mogués a l’entorn d’unes jornades que pretenien cultura de la solidaritat fonamentada en el respecte aconseguir tres objectius principals: d’una banda, dels drets humans en l’àmbit mundial. En el present obrir un espai de debat sobre quin és el paper dels i en el futur, LiberPress treballa i treballarà per mitjans de comunicació dins la societat (la seva col·laborar en l’execució de projectes que realitzin independència, la implicació en matèria de altres associacions humanitàries, com també per solidaritat i la influència que exerceixen en la impulsar els seus propis projectes. conscienciació sobre aquest àmbitmés solidari de la cultura), atesa la importància mediàtica i la LiberPress pretén, doncs, ésser un fòrum dirigit tant incidència que tenen en l’opinió pública; de l’altra, als professionals dels mitjans de comunicació com premiar els personatges
  • Sin Título-2

    Sin Título-2

    L’ESPORTIU PUNT DIVERS P22 Futbol Girona El Girona supera Detenen un violador 109004-1173374® el Montpeller en que els Mossos l’amistós (3-2) donaven per mort Bona primera part dels gironins en un Pensaven que s’havia ofegat al Ter quan partit que ha servit per donar rodatge fugia de la policia després d’haver a jugadors amb poca continuïtat agredit sexualment una dona a Flaçà 1,50€ Edició de Girona DISSABTE · 7 d’octubre del 2017. Any XLII. Núm. 14422 - AVUI / Any XXXIX. Núm. 13292 - EL PUNT CONSUM P8 Política P10 Medinyà anul·la la Els ajuntaments festa major pels fets violents de l’1-O proposen dos tècnics Llagostera bateja com a parc 1 d’Octubre l’espai on es van reunir els veïns per defensar el referèndum per a Aigües de Girona Política P17 SUBSTITUCIÓ · Han demanat CONTROL · Tres regidors dels El PSC de Blanes busca al jutjat que un enginyer i un ajuntaments de Girona, Salt i acords per a un nou govern ERC no descarta una moció de censura director financer ocupin el lloc Sarrià de Ter formen una entitat però veu difícil formar una alternativa del fins ara conseller delegat de gestió i controlaran Agissa Punt Divers P23 P6-7 SOCIETAT Intenten assaltar un mas a Cabanelles Vuit homes armats van arribar a la casa però l’inquilí va poder fugir GI-535-1978 Economia P12 Bona nota per a les legal: Dipòsit cooperatives gironines Amb el suport: Amb 122454-1171432w 17406 5 8 Premiats, organitzadors i autoritats en finalitzar la cerimònia d’entrega dels premis ■ JOAN SABATER 0 8 4 1 6 0 0 La dignitat dels Liberpress 7 3 4 Una urna va presidir simbòlicament l’acte de lliurament dels premis 8 SANITAT P12 Desconvoquen temporalment la vaga d’ambulàncies El comitè i TSC han arribat a un principi d’acord que haurà de ser ratificat per les 117711-1168804® Tall a l’N-II a Tordera l’1 de setembre ■ J.